Related references
Note: Only part of the references are listed.All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study
Bahar Moghaddam et al.
RHEUMATOLOGY (2022)
Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus
Kathleen R. Bashant et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study
Jeanette Halskou Haugaard et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Bite of the wolf: innate immune responses propagate autoimmunity in lupus
Sarthak Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug
Dori Abel et al.
PEDIATRIC RHEUMATOLOGY (2021)
PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease
Xiaosong Liu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
Sarfaraz A. Hasni et al.
NATURE COMMUNICATIONS (2021)
A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus
Brian J. Skaggs et al.
ACR OPEN RHEUMATOLOGY (2021)
Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
MacIntosh Grant Cornwell et al.
LUPUS SCIENCE & MEDICINE (2021)
Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years
Sofia Ajeganova et al.
LUPUS SCIENCE & MEDICINE (2021)
Immunological pathogenesis and treatment of systemic lupus erythematosus
Lu Pan et al.
WORLD JOURNAL OF PEDIATRICS (2020)
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome
Lucas L. van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis
Claudia Mendoza-Pinto et al.
ATHEROSCLEROSIS (2020)
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
Stanley Moore et al.
JOURNAL OF RHEUMATOLOGY (2020)
The Emerging Role of B Lymphocytes in Cardiovascular Disease
Luigi Adamo et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
Elisabet Svenungsson et al.
RHEUMATOLOGY (2020)
T cell subsets and functions in atherosclerosis
Ryosuke Saigusa et al.
NATURE REVIEWS CARDIOLOGY (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
T Cells in Autoimmunity-Associated Cardiovascular Diseases
Daniella Muallem Schwartz et al.
FRONTIERS IN IMMUNOLOGY (2020)
Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis
Jinoos Yazdany et al.
RMD OPEN (2020)
IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus
Xuewei Ding et al.
FRONTIERS IN IMMUNOLOGY (2020)
High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index
George Stojan et al.
LUPUS SCIENCE & MEDICINE (2020)
Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
Fangfang Sun et al.
LANCET RHEUMATOLOGY (2020)
Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
Sebastien Miranda et al.
PLOS ONE (2019)
Progression of atherosclerosis versus arterial stiffness with age within and between arteries in systemic lupus erythematosus
Paola C. Roldan et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Imaging Risk in Multisystem Inflammatory Diseases
Ignatios Ikonomidis et al.
JACC-CARDIOVASCULAR IMAGING (2019)
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
Saifur Rahman et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013)
Konstantinos Tselios et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
Yechen Han et al.
CARDIOVASCULAR DIABETOLOGY (2019)
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
Wen-Tao Ma et al.
FRONTIERS IN IMMUNOLOGY (2019)
Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus
Deng-Ho Yang et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy
Allison B. Reiss et al.
MEDICINA-LITHUANIA (2019)
Single-cell immune landscape of human atherosclerotic plaques
Dawn M. Fernandez et al.
NATURE MEDICINE (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous
Wan-Fang Lee et al.
PEDIATRIC RHEUMATOLOGY (2019)
Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus
Pragnesh Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Immunity and Inflammation in Atherosclerosis
Dennis Wolf et al.
CIRCULATION RESEARCH (2019)
The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis
Wenli Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
Development of a systemic lupus erythematosus cardiovascular risk equation
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance
Cintia N. H. Miyake et al.
ARTHRITIS CARE & RESEARCH (2018)
Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry
Holger Winkels et al.
CIRCULATION RESEARCH (2018)
Cardiorespiratory fitness and age-related arterial stiffness in women with systemic lupus erythematosus
Cristina Montalban-Mendez et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels
L. F. da Rosa Franchi Santos et al.
LUPUS (2018)
Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
Dan Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis
Yudong Liu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand
Linyu Geng et al.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2018)
Effects of 12-week Aerobic Exercise on Arterial Stiffness, Inflammation, and Cardiorespiratory Fitness in Women with Systemic LUPUS Erythematosus: Non-Randomized Controlled Trial
Alberto Soriano-Maldonado et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus
Philip M. Carlucci et al.
JCI INSIGHT (2018)
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
Abril Verden et al.
DRUG SAFETY (2018)
Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity
Carolyne K. Smith et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Hydroxychloroquine in systemic lupus erythematosus (SLE)
C. Ponticelli et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
Yasuko Furumoto et al.
ARTHRITIS & RHEUMATOLOGY (2017)
IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus
Joy Jones Buie et al.
JOURNAL OF IMMUNOLOGY (2017)
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Serena Fasano et al.
JOURNAL OF RHEUMATOLOGY (2017)
Immunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone
S. Mohammadi et al.
LUPUS (2017)
The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study
Marie-Louise Hermansen et al.
RHEUMATOLOGY (2017)
MR/PET Imaging of the Cardiovascular System
Philip M. Robson et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression
Anselm Mak et al.
SCIENTIFIC REPORTS (2017)
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Johanna T. Gustafsson et al.
PLOS ONE (2017)
Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition
Elmar Pieterse et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1 Pathway in Systemic Lupus Erythematosus
Sokha Nhek et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis
Carmelo Carmona-Rivera et al.
SCIENCE IMMUNOLOGY (2017)
Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome
Magar Ghazarian et al.
SCIENCE IMMUNOLOGY (2017)
Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis
Maria G. Tektonidou et al.
AUTOIMMUNITY REVIEWS (2017)
Effects of Long-Term Type I Interferon on the Arterial Wall and Smooth Muscle Progenitor Cells Differentiation
Yanpeng Diao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation
Christopher Tay et al.
CARDIOVASCULAR RESEARCH (2016)
Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis
Junzhe Chen et al.
CLINICAL RHEUMATOLOGY (2016)
T cells in Systemic Lupus Erythematosus
Abel Suarez-Fueyo et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus
Madhvi Menon et al.
IMMUNITY (2016)
Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis
Y. H. Lee et al.
LUPUS (2016)
Hydroxychloroquine, a promising choice for coronary artery disease?
Lizhe Sun et al.
MEDICAL HYPOTHESES (2016)
Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
Christian Lood et al.
NATURE MEDICINE (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study
Michele Iudici et al.
RHEUMATOLOGY (2016)
Dyslipidemia in systemic lupus erythematosus: just another comorbidity?
Konstantinos Tselios et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case-Control Study
Konstantinos Tselios et al.
ARTHRITIS CARE & RESEARCH (2016)
Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells
Sabrina Gruber et al.
CELL REPORTS (2016)
Mortality in Systemic Lupus Erythematosus: an Updated Review
Cesar E. Fors Nieves et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
Hsin-Hui Yu et al.
ATHEROSCLEROSIS (2015)
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Matthew A. Cavender et al.
CIRCULATION (2015)
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus
Elisabet Svenungsson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
CD4+CXCR3+T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus
Marc Clement et al.
JOURNAL OF AUTOIMMUNITY (2015)
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Annika Warnatsch et al.
SCIENCE (2015)
Normalization of CD4+ T cell metabolism reverses lupus
Yiming Yin et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus
Agostino Virdis et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome
Srilakshmi Yalavarthi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin
Haiting Wang et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice
Jason S. Knight et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice
Ashley J. Wilhelm et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2
Carmelo Carmona-Rivera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
Nicoletta Ronda et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Johanna T. Gustafsson et al.
AUTOIMMUNITY (2014)
Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis
Jason S. Knight et al.
CIRCULATION RESEARCH (2014)
Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
Enrica Golia et al.
CURRENT ATHEROSCLEROSIS REPORTS (2014)
Chronic Hydroxychloroquine Improves Endothelial Dysfunction and Protects Kidney in a Mouse Model of Systemic Lupus Erythematosus
Manuel Gomez-Guzman et al.
HYPERTENSION (2014)
Peroxisome proliferator-activated receptor gamma agonists in the prevention and treatment of murine systemic lupus erythematosus
Tamar R. Aprahamian et al.
IMMUNOLOGY (2014)
Increased Arterial Stiffness in Systemic Lupus Erythematosus (SLE) Patients at Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study
Karim Sacre et al.
PLOS ONE (2014)
A Panel of Biomarkers Is Associated With Increased Risk of the Presence and Progression of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Neutrophil Extracellular Trap-Derived Enzymes Oxidize High-Density Lipoprotein An Additional Proatherogenic Mechanism in Systemic Lupus Erythematosus
Carolyne K. Smith et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Relation of Carotid Intima-Media Thickness and Plaque With Incident Cardiovascular Events in Women With Systemic Lupus Erythematosus
Amy H. Kao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus
Wenpu Zhao et al.
CLINICAL IMMUNOLOGY (2013)
Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with Systemic Lupus Erythematosus (SLE)
Zhu Mengya et al.
CLINICAL RHEUMATOLOGY (2013)
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus
Jason S. Knight et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Macrophage Clearance of Neutrophil Extracellular Traps Is a Silent Process
Consol Farrera et al.
JOURNAL OF IMMUNOLOGY (2013)
Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases
L. Bouillet et al.
LABORATORY INVESTIGATION (2013)
BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE-/- Mice
Tin Kyaw et al.
PLOS ONE (2013)
Measurement of Arterial Activity on Routine FDG PET/CT Images Improves Prediction of Risk of Future CV Events
Amparo L. Figueroa et al.
JACC-CARDIOVASCULAR IMAGING (2013)
BAFF Receptor Deficiency Reduces the Development of Atherosclerosis in Mice-Brief Report
Andrew P. Sage et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Use of atorvastatin in systemic lupus erythematosus in children and adolescents
L. E. Schanberg et al.
ARTHRITIS AND RHEUMATISM (2012)
Type I Interferons Modulate Vascular Function, Repair, Thrombosis, and Plaque Progression in Murine Models of Lupus and Atherosclerosis
Seth G. Thacker et al.
ARTHRITIS AND RHEUMATISM (2012)
Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial
J. G. Juarez-Rojas et al.
LUPUS (2012)
Activation of PAD4 in NET formation
Amanda S. Rohrbach et al.
FRONTIERS IN IMMUNOLOGY (2012)
Arterial Stiffening, Wave Reflection, and Inflammation in Habitually Exercising Systemic Lupus Erythematosus Patients
Jill N. Barnes et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Lupus Atherosclerosis Prevention Study (LAPS)
M. A. Petri et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Interferon-α Priming Promotes Lipid Uptake and Macrophage-Derived Foam Cell Formation A Novel Link Between Interferon-α and Atherosclerosis in Lupus
Jia Li et al.
ARTHRITIS AND RHEUMATISM (2011)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus
Eneida Villanueva et al.
JOURNAL OF IMMUNOLOGY (2011)
Endothelium-dependent But Not Endothelium-independent Flow-mediated Dilation Is Significantly Reduced in Patients with Systemic Lupus Erythematosus without Vascular Events: A Metaanalysis and Metaregression
Anselm Mak et al.
JOURNAL OF RHEUMATOLOGY (2011)
An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus
B. Parker et al.
LUPUS (2011)
Macrophage Activation and Coronary Atherosclerosis in Systemic Lupus Erythematosus and Rheumatoid Arthritis
Young Hee Rho et al.
ARTHRITIS CARE & RESEARCH (2011)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease
Christian Lood et al.
BLOOD (2010)
Arterial Stiffness and Cardiovascular Events The Framingham Heart Study
Gary F. Mitchell et al.
CIRCULATION (2010)
The Th17/Treg functional imbalance during atherogenesis in ApoE-/- mice
Jiang-jiao Xie et al.
CYTOKINE (2010)
Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development
Philipp Enghard et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
E. Maury et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells
S. G. Thacker et al.
LUPUS (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus
C. C. Mok et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus
Pierre Duffau et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
Cristina Anania et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Dysfunctional Proinflammatory High-Density Lipoproteins Confer Increased Risk of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2009)
Th17 and Natural Treg Cell Population Dynamics in Systemic Lupus Erythematosus
Ji Yang et al.
ARTHRITIS AND RHEUMATISM (2009)
Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery-Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells
Raymond E. Eid et al.
CIRCULATION (2009)
Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study The Multi-Ethnic Study of Atherosclerosis
Joseph Yeboah et al.
CIRCULATION (2009)
The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus
Wenpu Zhao et al.
JOURNAL OF IMMUNOLOGY (2009)
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
Jane E. Salmon et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Accumulation of coronary artery disease risk factors actors over three years:: Data from an international inception cohort
M. B. Urowitz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Inflammation-associated insulin resistance - Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms
Cecilia P. Chung et al.
ARTHRITIS AND RHEUMATISM (2008)
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus
Ram Kumar Chowdary Venigalla et al.
ARTHRITIS AND RHEUMATISM (2008)
Adiponectin and inflammation: Consensus and controversy
Giamila Fantuzzi
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus
Q. Shang et al.
LUPUS (2008)
Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus
Pui Y. Lee et al.
ARTHRITIS AND RHEUMATISM (2007)
Cardiac involvement in systemic inflammatory diseases
Daniel C. Knockaert
EUROPEAN HEART JOURNAL (2007)
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid
Daniel Mucida et al.
SCIENCE (2007)
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors
Cecilia P. Chung et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort
M. B. Urowitz et al.
LUPUS (2007)
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Stephane Laurent et al.
EUROPEAN HEART JOURNAL (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis
MJ Roman et al.
ANNALS OF INTERNAL MEDICINE (2006)
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population
TW Hansen et al.
CIRCULATION (2006)
Platelet C4d is highly specific for systemic lupus erythematosus
JS Navratil et al.
ARTHRITIS AND RHEUMATISM (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
'Not only ... but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
IN Bruce
RHEUMATOLOGY (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Adipose tissue, inflammation, and cardiovascular disease
AH Berg et al.
CIRCULATION RESEARCH (2005)
MRL/Mp CD4+,CD25-T cells show reduced sensitivity to suppression by CD4+,CD25+regulatory T cells in vitro - A novel defect of T cell regulation in systemic lupus erythematosus
CR Monk et al.
ARTHRITIS AND RHEUMATISM (2005)
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations
J Frostegard et al.
ARTHRITIS AND RHEUMATISM (2005)
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
S Malik et al.
CIRCULATION (2004)
Endothelial dysfunction
DH Endemann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management
J Wajed et al.
RHEUMATOLOGY (2004)
Anti-lipoprotein lipase antibodies -: A new player in the complex atherosclerotic process in systemic lupus erythematosus?
JF de Carvalho et al.
ARTHRITIS AND RHEUMATISM (2004)
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
S Rajagopalan et al.
BLOOD (2004)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
MJ Roman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
HM Lakka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
